Skip to main content
SpringerLink
Log in

Endocrinology of Epithelial Ovarian Cancer

  • Chapter
Endocrine Oncology

Part of the book series: Contemporary Endocrinology ((COE))

  • 134 Accesses

Abstract

Epithelial ovarian carcinoma occurs as a consequence of multiple genetic mutations of the ovarian surface epithelial cell (EC). The vast majority of these cases (>90%) are sporadic rather than familial. Although the pathogenesis of epithelial ovarian cancer (OC) has not been fully defined, a growing body of evidence indicates that endocrinologic factors exert significant influences on both the development and the progression of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mckay DG. The adult human ovary: a histochemical study. Obstet Gynecol 1961; 18: 13–39.

    PubMed  CAS  Google Scholar 

  2. Blaustein A. Peritoneal mesothelium and ovarian surface cells: shared characteristics. Int J Gynecol Pathol 1984; 3: 361–375.

    Article  PubMed  CAS  Google Scholar 

  3. Nicosia SV, Johnson JH. Surface morphology of ovarian mesothelium (surface epithelium) and of other pelvic and extrapelvic mesothelial sites in the rabbit. Int J Gynecol Pathol 1984; 3: 249–260.

    Article  PubMed  CAS  Google Scholar 

  4. Blaustein A, Lee H. Surface cells of the ovary and pelvic peritoneum: a histochemical and ultrastructural comparison. Gynecol Oncol 1979; 8: 34.

    Article  PubMed  CAS  Google Scholar 

  5. Nouwen EJ, Hendrix PG, Dauwe S, et al. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol 1987; 126: 230–242.

    PubMed  CAS  Google Scholar 

  6. Maines-Bandiera SL, Auersperg N. Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int J Gynecol Pathol 1997; 16: 250–255.

    Article  PubMed  CAS  Google Scholar 

  7. Sundfeldt K, Piontkewitz Y, Ivarsson K, et al. E-cadherin expression in human epithelial ovarian cancer and normal ovary.Int J Cancer 1997; 74: 275–280.

    CAS  Google Scholar 

  8. Hamilton TC, Davies P, Griffiths K, et al. Oestrogen receptor-like binding in the surface germinal epithelium of the rat ovary. J Endocrinol 1982; 95: 377–385.

    Article  PubMed  CAS  Google Scholar 

  9. Zheng W, Magid MS, Kramer EE, Chen YT. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 1996; 148: 47–53.

    PubMed  CAS  Google Scholar 

  10. Eltabbakh GH, Piver MS. Extraovarian primary peritoneal carcinoma. Oncology 1998; 12: 813–819.

    PubMed  CAS  Google Scholar 

  11. Eltabbakh GH, Piver MS, Natarajan N, Mettlin CJ. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 1998; 91: 254–259.

    Article  PubMed  CAS  Google Scholar 

  12. Kruk PA, Uitto VJ, Firth JD, et al. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp Cell Res 1994; 215: 97–108.

    Article  PubMed  CAS  Google Scholar 

  13. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184–1203.

    PubMed  CAS  Google Scholar 

  14. Franceschi S, Parazzini F, Negri E, et al. Pooled analysis of 3 European case-control studies. III. Oral contraceptive use. Int J Cancer 1991; 49: 61–65.

    Article  PubMed  CAS  Google Scholar 

  15. Radisklavejevic SV. The pathogenesis of ovarian inclusion cysts and cystadenomas. Obstet Gynecol 1977; 49: 424–429.

    Google Scholar 

  16. Clement PB. Nonneoplastic lesions of the ovary. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract, 3rd ed. Springer, Berlin, New York, 1987, pp. 471–496.

    Google Scholar 

  17. Scully RE. Ovarian tumors. A review. Am J Pathol 1997; 87: 686–720.

    Google Scholar 

  18. Nicosia X, et al. In: Familiari G, Sayoko, M, Pietro M, eds. Ultrastructure of the Ovary. Klewer, The Netherlands, 1991, pp. 287–310.

    Google Scholar 

  19. Mendelsohn ML. The somatic mutational component of human carcinogenesis. In: Moolgavkar SH, ed. Scientific Issues in Quantitative Cancer Risk Assessment. Birkhaeuser, Boston, New York, 1990, pp. 22–31.

    Chapter  Google Scholar 

  20. Hamilton TC. Ovarian cancer: part I: biology. Curr Probl Cancer 1992; 16: 1–57.

    Article  PubMed  CAS  Google Scholar 

  21. Godwin AK, Testa JR, Handel LM, et al. Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 1992; 84: 592–601.

    Article  PubMed  CAS  Google Scholar 

  22. Rodriguez GC. Walmer DK, Cline M, et al. Effect of progestins on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Invest 1998; 5: 271–276.

    Article  Google Scholar 

  23. Rodriguez C, Calle EE, Coates RJ, et al. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141: 828–835.

    PubMed  CAS  Google Scholar 

  24. Cardillo MR, Petrangeli E, Aliotta N, et al. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J Exp Clin Cancer Res 1998; 17: 231–237.

    PubMed  CAS  Google Scholar 

  25. Thompson MA, Adelson MD. Aging and development of ovarian epithelial carcinoma: the relevance of changes in ovarian stromal androgen production. Adv Exp Med Biol 1993; 330: 155–165.

    Article  PubMed  CAS  Google Scholar 

  26. Langdon SP, Hawkes MM, Lawrie SS, et al. Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer 1990; 62: 213–216.

    Article  PubMed  CAS  Google Scholar 

  27. Hua W, Christianson T, Rougeot C, et al. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and anti-estrogens. J Steroid Biochem Mol Med 1995; 55: 279–289.

    Article  CAS  Google Scholar 

  28. Schiffernbauer YS, Abramovitch R, Meir G, et al. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 1997; 94: 13203–13208.

    Article  Google Scholar 

  29. Rochefort H, Platet N, Hayashido Y, et al. Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 1998; 65: 163–168.

    Article  PubMed  CAS  Google Scholar 

  30. Hamilton TC, Davies P, Griffiths K. Steroid-hormone receptor status of the normal and neoplastic ovarian surface germinal epithelium. In: Greenwald GS, Terranova PF, eds. Factors Regulating Ovarian Function. Raven, New York, 1983, pp. 81–85.

    Google Scholar 

  31. Nash JD, Ozols RF, Smyth JF, Hamilton TC. Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet Gynecol 1989; 73: 1009–1016.

    Article  PubMed  CAS  Google Scholar 

  32. Batra S, Iosif CS. Elevated concentrations of antiestrogen binding sites in membrane fractions of human ovarian tumors. Gynecol Oncol 1996; 60: 228–232.

    Article  PubMed  CAS  Google Scholar 

  33. Ahlgren JD, Ellison NM, Gottlieb RJ, et al. Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program. J Clin Oncol 1993; 11: 1957–1968.

    PubMed  CAS  Google Scholar 

  34. Hatch KD, Beecham JB, Blessing JA, Creasman WT. Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients. Cancer 1991; 68: 269–271.

    Article  PubMed  CAS  Google Scholar 

  35. Scambia G, Ranelletti FO, Benedetti Panici P, et al. Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours. Eur J Cancer 1992; 28A: 1885–1889.

    Article  Google Scholar 

  36. Schwartz PE, Chambers JP, Kohorn EI, et al. Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. Cancer 1989; 63: 1074.

    Article  PubMed  CAS  Google Scholar 

  37. Rice BF, Savard K. Steroid hormone formation in the human ovary. IV. Ovarian stromal compartment: formation of radioactive steroids from acetate-I-14C and action of gonadotropins. J Clin Endocrinol 1966; 26: 593–609.

    Article  CAS  Google Scholar 

  38. Schildkraut JM, Schwingel PJ, Bastos E, et al. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996; 88: 554–559.

    Article  PubMed  CAS  Google Scholar 

  39. Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropoins and steroid hormones and the development of ovarian cancer. JAMA 1995; 274: 1926–1930.

    Article  PubMed  CAS  Google Scholar 

  40. Heinonen PK. Androgen production by epithelial ovarian tumors in post-menopausal women. Maturitas 1991; 13: 117–122.

    Article  PubMed  CAS  Google Scholar 

  41. Blaakaer J, Micic S, Morris ID, et al. Immunoreactive inhibin-production in postmenopausal women with malignant epithelial tumors. Eur J Obstet Gynecol Repro Biol 1993; 52: 105–110.

    Article  CAS  Google Scholar 

  42. Silva EG, Tornos C, Fritsche HA, et al. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Modern Pathol 1997; 10: 879–883.

    CAS  Google Scholar 

  43. Kuhnel R, de Graaff J, Rao BR, Stolk JG. Androgen receptor predominance in human ovarian carcinoma. J Steroid Biochem 1987; 26: 393–397.

    Article  PubMed  CAS  Google Scholar 

  44. Kavanagh JJ, Wharton JT, Roberts WS. Androgen therapy in the treatment of refractory epithelial ovarian cancer. Cancer Treat Rep 1987; 71: 537–538.

    PubMed  CAS  Google Scholar 

  45. Tumolo S, Rao BR, van der Burg ME, et al. Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynecologic Cancer Cooperative Study. Eur J Cancer 1994; 30A: 911–914.

    Article  Google Scholar 

  46. Biskind MS, Biskin GS. Development of tumors in the rat ovary after transplantation into the spleen. Proc Soc Exp Biol Med 1944; 55: 176–179.

    CAS  Google Scholar 

  47. Makabe S, Iwaka A, Hafez ES, Motta PM. Physiomorphology of fertile and infertile human ovaries. In: Motta PM, Hafez ESE, eds. Biology of the Ovary. Nijhoff, The Hague, 1980, pp. 279–290.

    Chapter  Google Scholar 

  48. Blaakaer J, Baeksted M, Micic S, et al. Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biol Reprod 1995; 53: 775–779.

    Article  PubMed  CAS  Google Scholar 

  49. Al-Timimi A, Buckley CH, Fox X. An immunohistochemical study of the incidence and significance of human gonadotropin and prolactin binding sites in normal and neoplastic human ovarian tissue. Br J Cancer 1986; 53: 321–329.

    Article  PubMed  CAS  Google Scholar 

  50. Osterholzer HO, Streibel EJ, Nicosia S V. Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 1985; 33: 247–258.

    Article  PubMed  CAS  Google Scholar 

  51. Feng Y, Zhang X, Gi B. Gonadotropins stimulate the proliferation of human epithelial ovarian cancer cells. Chin J Obstet Gynecol 1996; 31: 166–168.

    CAS  Google Scholar 

  52. Ohtani K, Sakamoto H, Satoh K. Stimulatory effects of follicular stimulating hormone on the proliferation of ovarian cancer cell lines in vitro and in vivo. Acta Obstet Gynecol Jpn 1992; 44: 717–724.

    CAS  Google Scholar 

  53. Emons G, Ortmann O, Teichert HM, et al. Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group. Cancer 1996; 78: 1452–1460.

    Article  PubMed  CAS  Google Scholar 

  54. Erickson LD, Hartmann LC, Su JQ, et al. Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III and IV ovarian carcinoma. Gynecol Oncol 1994; 54: 196–200.

    Article  PubMed  CAS  Google Scholar 

  55. Blaakaer J, Djursing H, Hording U, et al. The pituitary-gonodal axis in women with benign or malignant ovarian tumors. Acta Endocrinol 1992; 127: 127–130.

    PubMed  CAS  Google Scholar 

  56. Mahlck G, Grankvist K, Kjellgren O, Backstrom T. Human chorionic gonadotropin, follicle-stimulating hormone, and luteinizing hormone in patients with epithelial ovarian carcinoma. Gynecol Oncol 1990; 36: 219–225.

    Article  PubMed  CAS  Google Scholar 

  57. Burger HG, Robertson DM, Cahirn N, et al. Characterization of inhibin immunoreactivity in postmenopausal women with ovarian tumors. Clin Endocr 1996; 55: 413–418.

    Article  Google Scholar 

  58. Healy DL, Mamers P, Bangah M, Burger HG. Clinical and pathophysiological aspects of inhibin. Human Reprod 1993; 8: 138–140.

    CAS  Google Scholar 

  59. Scully RE. Tumors of the ovary and maldeveloped gonads. In: Atlas of Tumor Pathology, Second Series, Fascicle 16. Armed Forces Institute of Pathology, Washington, DC, 1979.

    Google Scholar 

  60. Giordano G, Barreca A, Minuto F. Growth factors in the ovary. J Endocrinol Invest 1992; 15: 689–707.

    PubMed  CAS  Google Scholar 

  61. Wang D, Konishi I, Koshiyama M, et al. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumors of the ovary. Virchows Arch A Pathol Anat 1992; 421: 393–400.

    Article  CAS  Google Scholar 

  62. Marquardt H, Hunkapillar MW, Hood LE, Todaro GJ. Rat transforming growth factor alpha, structure and relation to epidermal growth factor. Science 1984; 223: 1079.

    Article  PubMed  CAS  Google Scholar 

  63. Roy SK, Greenwald GS. Immunohistochemical localization of epidermal growth factor-like activity in the hamster ovary with a polyclonal antibody. Endocrinology 1990; 126: 1309.

    Article  PubMed  CAS  Google Scholar 

  64. Kudlow JE, Kobrin MS, Purchio AF, et al. Ovarian transforming growth factor alpha gene expresion: immunohistochemical localization to the theca-interstitial cells. Endocrinology 1987; 121: 1577.

    Article  PubMed  CAS  Google Scholar 

  65. Simpson BJ, Langdon SP, Rabiasz GJ, et al. Estrogen regulation of transforming growth factor alpha in ovarian cancer. J Steroid Biochem Mol Biol 1998; 64: 137–145.

    Article  PubMed  CAS  Google Scholar 

  66. Jindal SK, Snoey DM, Lobb DK, Dorrington JH. Transforming growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol Oncol 1994; 53: 17–23.

    Article  PubMed  CAS  Google Scholar 

  67. Rodriguez GC, et al. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. III. Relationship between receptor expression and response to epidermal growth factor. Am J Oncol Gynecol 1991; 164: 745–750.

    CAS  Google Scholar 

  68. Pierroet E, Nicosia SV, Saunders B, et al. Influence of growth factors on proliferation and morphogenesis of rabbit ovarian mesothelial cells in vitro. Biol Reprod 1996; 54: 660–669.

    Article  Google Scholar 

  69. Rosenthal A, Lindquist PB, Bringman TS, et al. Expression in rat fibroblasts of a human transforming growth factor alpha cDNA results in transformation. Cell 1986; 46: 301.

    Article  PubMed  CAS  Google Scholar 

  70. Stern DF, Hare DL, Cecchini MA, Weinberg RA. Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 1987; 235: 321.

    Article  PubMed  CAS  Google Scholar 

  71. Stromberg K, Collins TJ, Gordon AW, et al. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res 1992; 52: 341–347.

    PubMed  CAS  Google Scholar 

  72. Morishige K, Kurachi H, Amemiya X, et al. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro. Cancer Res 1991; 51: 5951–5955.

    PubMed  CAS  Google Scholar 

  73. Havrilesky LJ, Hurteau JA, Whitaker RS, et al. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Cancer Res 1995; 55: 944–948.

    PubMed  CAS  Google Scholar 

  74. Bartlett JM, Langdon SP, Scott WN, et al. Transforming growth factor-beta isoform expression in human ovarian tumours. Eur J Cancer 1997; 33: 2397–2403.

    Article  PubMed  CAS  Google Scholar 

  75. Nakanishi Y, Kodama J, Yoshiniouchi M, et al. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer. Int J Obstet Gynecol Pathol 1997; 16: 256–262.

    Article  CAS  Google Scholar 

  76. Hurteau J, Rodriguez GC, Whitaker RS, et al. Transforming growth factor beta inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 1994; 74: 93–99.

    Article  PubMed  CAS  Google Scholar 

  77. Bauchnect T, Birmelin G, Kommoss F. Clinical significance of oncogenes and growth factors in ovarian carcinoma. J Steroid Biochem Mol Biol 1990; 37: 855–862.

    Article  Google Scholar 

  78. Resnicoff M, Ambrose D, Coppola D, Rubin R. Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Invest 1993; 69: 756–760.

    PubMed  CAS  Google Scholar 

  79. Setrakian S, Oliveros-Saunders B, Nicosia SV. Growth stimulation of ovarian and extraovarian mesothelial cells by corpus luteum extract. In Vitro Cell Dev Biol Animal 1993; 29A: 879–883.

    Article  Google Scholar 

  80. Khan SA, Matysiak-Zablocki E, Ball R, et al. Steroidogenesis-inducing protein, isolated from human ovarian follicular fluid, is a potent mitogen for cell lines derived from ovarian surface epithelial carcinomas. Gynecol Oncol 1997; 66: 501–508.

    Article  PubMed  CAS  Google Scholar 

  81. Huseby RA, Maloney TM, McGrath CM. Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vivo. Cancer Res 1984; 44: 2654.

    Google Scholar 

  82. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. Clin Endocr Metabol 1996; 81: 353–359.

    Article  CAS  Google Scholar 

  83. Barton DP, Cai A, Wendt K, et al. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 1997; 3: 1579–1586.

    PubMed  CAS  Google Scholar 

  84. Baker VV. The molecular genetics of epithelial ovarian cancer. Obstet Gynecol Clin N Am 1994; 21: 25–40.

    CAS  Google Scholar 

  85. Wyllie AH. Apoptosis and carcinogenesis. Eur J Cell Biol 1997; 73: 189–197.

    PubMed  CAS  Google Scholar 

  86. Berchuck A. Kohler MF, Marks JR, et al. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol 1994; 170: 246–252.

    PubMed  Google Scholar 

  87. Schildkraut JM, Bastos E, Berchuck A. Relationship between lifetime ovulatory cycles and an expression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 1997; 89: 932–938.

    Article  PubMed  CAS  Google Scholar 

  88. Jennings TS, Dottino PR, Mandeli JP, et al. Growth factor expression in normal peritoneum of patients with gynecologic carcinoma. Gynecol Oncol 1994; 55: 190.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Vicki V. Baker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Michigan Cancer Center, Ann Arbor, MI, USA

    Stephen P. Ethier PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Baker, V.V. (2000). Endocrinology of Epithelial Ovarian Cancer. In: Ethier, S.P. (eds) Endocrine Oncology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-223-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-223-4_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9700-7

  • Online ISBN: 978-1-59259-223-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation